Access the full text.
Sign up today, get DeepDyve free for 14 days.
P. Srikanthan, A. Hevener, A. Karlamangla (2010)
Sarcopenia Exacerbates Obesity-Associated Insulin Resistance and Dysglycemia: Findings from the National Health and Nutrition Examination Survey IIIPLoS ONE, 5
M. Mráz, M. Bártlová, Z. Lacinová, D. Michalský, Mojmir Kasalicky, D. Haluzíková, Martin Matoulek, I. Dostálová, V. Humenanská, M. Haluzík (2009)
Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor‐21 in patients with type 2 diabetes and obesityClinical Endocrinology, 71
D. Yi, A. Khang, H. Lee, S. Son, Y. Kang (2018)
Relative handgrip strength as a marker of metabolic syndrome: the Korea National Health and Nutrition Examination Survey (KNHANES) VI (2014–2015)Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 11
S. Keipert, M. Ost, Kornelia Johann, Francine Imber, M. Jastroch, E. Schothorst, J. Keijer, S. Klaus (2014)
Skeletal muscle mitochondrial uncoupling drives endocrine cross-talk through the induction of FGF21 as a myokine.American journal of physiology. Endocrinology and metabolism, 306 5
R. Gimeno, D. Moller (2014)
FGF21-based pharmacotherapy – potential utility for metabolic disordersTrends in Endocrinology & Metabolism, 25
Beom-Jun Kim, Seong Ahn, Seung Lee, S. Hong, M. Hamrick, C. Isales, J. Koh (2019)
Lower hand grip strength in older adults with non-alcoholic fatty liver disease: a nationwide population-based studyAging (Albany NY), 11
K. Sanada, K. Sanada, M. Miyachi, Michiya Tanimoto, Kenta Yamamoto, H. Murakami, Shigetoshi Okumura, Y. Gando, Katsuhiko Suzuki, I. Tabata, Mitsuru Higuchi (2010)
A cross-sectional study of sarcopenia in Japanese men and women: reference values and association with cardiovascular risk factorsEuropean Journal of Applied Physiology, 110
Tetsuya Nishimura, Yuhki Nakatake, M. Konishi, N. Itoh (2000)
Identification of a novel FGF, FGF-21, preferentially expressed in the liver.Biochimica et biophysica acta, 1492 1
A. Kharitonenkov, T. Shiyanova, A. Koester, Amy Ford, R. Micanovic, E. Galbreath, G. Sandusky, L. Hammond, J. Moyers, R. Owens, J. Gromada, J. Brozinick, E. Hawkins, V. Wroblewski, Deshan Li, F. Mehrbod, S. Jaskunas, A. Shanafelt (2005)
FGF-21 as a novel metabolic regulator.The Journal of clinical investigation, 115 6
A. Cruz-Jentoft, G. Bahat, J. Bauer, Y. Boirie, O. Bruyère, T. Cederholm, C. Cooper, F. Landi, Y. Rolland, A. Sayer, S. Schneider, C. Sieber, E. Topinkova, M. Vandewoude, M. Visser, M. Zamboni, I. Bautmans, J. Baeyens, M. Cesari, A. Cherubini, J. Kanis, M. Maggio, F. Martin, J. Michel, K. Pitkala, J. Reginster, R. Rizzoli, D. Sánchez-Rodríguez, J. Schols (2018)
Sarcopenia: revised European consensus on definition and diagnosisAge and Ageing, 48
Liang‐Kung Chen, Li-Kuo Liu, J. Woo, P. Assantachai, T. Auyeung, KamaruzzamanShahrul Bahyah, M. Chou, LiangYu Chen, P. Hsu, O. Krairit, Jenny Lee, Wei‐Ju Lee, Yunhwan Lee, C. Liang, P. Limpawattana, Chu-Sheng Lin, L. Peng, S. Satake, Takao Suzuki, C. Won, Chih-Hsing Wu, Si-nan Wu, Teimei Zhang, P. Zeng, M. Akishita, H. Arai (2014)
Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia.Journal of the American Medical Directors Association, 15 2
T. Coskun, H. Bina, Michael Schneider, J. Dunbar, Charlie Hu, Yanyun Chen, D. Moller, A. Kharitonenkov (2008)
Fibroblast growth factor 21 corrects obesity in mice.Endocrinology, 149 12
R. Baumgartner, K. Koehler, D. Gallagher, L. Romero, S. Heymsfield, R. Ross, P. Garry, R. Lindeman (1998)
Epidemiology of sarcopenia among the elderly in New Mexico.American journal of epidemiology, 147 8
B. Goodpaster, S. Park, T. Harris, S. Kritchevsky, M. Nevitt, A. Schwartz, E. Simonsick, F. Tylavsky, M. Visser, A. Newman (2006)
The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study.The journals of gerontology. Series A, Biological sciences and medical sciences, 61 10
J. Dushay, P. Chui, G. Gopalakrishnan, M. Varela-Rey, M. Crawley, F. Fisher, M. Badman, M. Martínez‐Chantar, E. Maratos-Flier (2010)
Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease.Gastroenterology, 139 2
Seong Kim, Kook Kim, Hyoung-Kyu Kim, Mi‐jeong Kim, S. Back, M. Konishi, N. Itoh, Myung-Shik Lee (2015)
Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stressDiabetologia, 58
C. Won, Seoyoon Lee, Jinhee Kim, D. Chon, Sunyoung Kim, Chang-O Kim, Mi Kim, B. Cho, K. Choi, E. Roh, H. Jang, S. Son, Jin-Hee Lee, Y. Park, Sam-Gyu Lee, B. Kim, H. Kim, Jaekyung Choi, H. Ga, Kee-Jae Lee, Yunhwan Lee, Miji Kim (2020)
Korean frailty and aging cohort study (KFACS): cohort profileBMJ Open, 10
Xinmei Zhang, D. Yeung, M. Karpíšek, D. Stejskal, Zhiguang Zhou, Feng Liu, R. Wong, W. Chow, A. Tso, K. Lam, A. Xu (2008)
Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in HumansDiabetes, 57
Kook Kim, Yeon Jeong, Hyunhee Oh, Seong Kim, Jae-min Cho, Yo-Na Kim, Su Kim, Do Kim, K. Hur, Hyoung-Kyu Kim, T. Ko, Jin Han, Hong Kim, J. Kim, S. Back, M. Komatsu, Hsiuchen Chen, D. Chan, M. Konishi, N. Itoh, C. Choi, Myung-Shik Lee (2012)
Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokineNature Medicine, 19
B. Clark, T. Manini (2010)
Functional consequences of sarcopenia and dynapenia in the elderlyCurrent Opinion in Clinical Nutrition and Metabolic Care, 13
Saswata Talukdar, Yingjiang Zhou, Dongmei Li, M. Rossulek, Jennifer Dong, V. Somayaji, Y. Weng, R. Clark, Adhiraj Lanba, B. Owen, M. Brenner, J. Trimmer, K. Gropp, Jeffrey Chabot, D. Erion, T. Rolph, B. Goodwin, R. Calle (2016)
A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects.Cell metabolism, 23 3
H. Tyynismaa, C. Carroll, N. Raimundo, Sofia Ahola-Erkkilä, T. Wenz, Heini Ruhanen, K. Guse, A. Hemminki, Katja Peltola-Mjøsund, Valtteri Tulkki, M. Orešič, C. Moraes, K. Pietiläinen, I. Hovatta, A. Suomalainen (2010)
Mitochondrial myopathy induces a starvation-like response.Human molecular genetics, 19 20
Scott Ebert, Michael Dyle, S. Bullard, Jason Dierdorff, D. Murry, Daniel Fox, K. Bongers, V. Lira, D. Meyerholz, J. Talley, C. Adams (2015)
Identification and Small Molecule Inhibition of an Activating Transcription Factor 4 (ATF4)-dependent Pathway to Age-related Skeletal Muscle Weakness and AtrophyThe Journal of Biological Chemistry, 290
D. Leong, K. Teo, S. Rangarajan, P. López-Jaramillo, Á. Avezum, A. Orlandini, P. Serón, Suad Ahmed, A. Rosengren, R. Kelishadi, O. Rahman, S. Swaminathan, R. Iqbal, Rajeev Gupta, S. Lear, A. Oguz, K. Yusoff, K. Zatońska, J. Chifamba, E. Igumbor, V. Mohan, R. Anjana, H. Gu, Wei Li, S. Yusuf (2015)
Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) studyThe Lancet, 386
I. Janssen, S. Heymsfield, R. Ross (2002)
Low Relative Skeletal Muscle Mass (Sarcopenia) in Older Persons Is Associated with Functional Impairment and Physical DisabilityJournal of the American Geriatrics Society, 50
T. Laeger, Diana Albarado, Susan Burke, L. Trosclair, John W. Hedgepeth, H. Berthoud, T. Gettys, J. Collier, H. Münzberg, Christopher Morrison (2016)
Metabolic Responses to Dietary Protein Restriction Require an Increase in FGF21 that Is Delayed by the Absence of GCN2.Cell reports, 16 3
T. Moro, Scott Ebert, C. Adams, B. Rasmussen (2016)
Amino Acid Sensing in Skeletal MuscleTrends in Endocrinology & Metabolism, 27
Gyu Kim, Jiyu Sun, M. Han, Sohee Park, C. Nam (2019)
Impact of handgrip strength on cardiovascular, cancer and all-cause mortality in the Korean longitudinal study of ageingBMJ Open, 9
K. Tacer, A. Bookout, Xunshan Ding, H. Kurosu, G. John, Lei Wang, R. Goetz, M. Mohammadi, M. Kuro-o, D. Mangelsdorf, S. Kliewer (2010)
Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse.Molecular endocrinology, 24 10
Backgrounddespite of the beneficial effects of fibroblast growth factor (FGF) 21 in several metabolic diseases, the association of plasma FGF21 with muscle mass and muscle strength is still unclear.Methodsa total of 386 community-dwelling older adults aged 70–84 years were analysed. Appendicular skeletal muscle mass was measured using dual-energy X-ray absorptiometry and normalised to the square of height (ASM/ht2). Muscle strength was assessed using the hand grip strength (HGS) test. The definitions of low muscle mass (LMM) and low muscle strength (LMS) were based on the Asian Working Group for Sarcopenia.Resultsplasma FGF21 was significantly lower in participants with LMM than in those with normal muscle mass (289.7 [192.4–448.3] vs. 345.6 [238.6–503.2] pg/ml, P = 0.008). In contrast, the LMS group had a significantly higher plasma FGF21 level than the normal muscle strength group (369.7 [244.4–591.1] vs. 309.7 [205.3–444.8] pg/ml, P = 0.006). In the partial correlation analysis, following adjustment for age, sex and body mass index, FGF21 levels had no significant association with ASM/ht2, but were negatively associated with HGS (r = −0.112, P = 0.029). Furthermore, after multivariate adjustment for confounding variables, the odds ratio for the risk of LMS was 2.32 (95% confidence interval 1.20–4.46) when comparing the highest with the lowest FGF21 quartile.Conclusionscirculating FGF21 levels are negatively associated with muscle strength but are not independently correlated with muscle mass.
Age and Ageing – Oxford University Press
Published: Sep 27, 2021
Keywords: fibroblast growth factor (FGF) 21; muscle mass; muscle strength; sarcopenia; older adults
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.